Companies / Italy
Chiron Withdraws MMR Vaccine From Market
March 2006 | Company Finance AlertChiron has withdrawn its Morupar MMR vaccine from markets in Italy, Syria and Jordan over side effect concerns, further compounding the US biotech company's problems as it recovers from the flu vaccine shortage
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
